Therapeutic+effects+of+Glatiramer+Acetate,+Copaxone,+in+Alzheimer's+Disease+Experiments

=Therapeutic effects of Glatiramer Acetate, Copaxone, in Alzheimer's Disease Models=


 * Resources:**

[1] Saunders AJ, Tanzi RE. Welcome to the Complex Disease World: Alpha2-Macroglobulin and Alzheimer’s Disease. Exp Neurol.2003, 184**(1)**:50-53.[|DOI] [2] Saunders AJ, Puglielli L, Ellis BC, Kovacs DM. Ceramide Stabilizes beta - Site Amyloid Precursor Protein-cleaving Enzyme 1 and Promotes Amyloid beta - Peptide Biogenesis. J Biol Chem. 2003 278**(22**):19777-19783. [|DOI] [3] Butovsky O, Kunis G, Koronyo-Hamaoui M, Schwartz M. Selective Ablation of Bone Marrow-Derived Dendritic Cells Increases Amyloid Plaques in Mouse Alzheimer's Disease Models. Euro. J Neuroscience. 2007 26**(2)**: 413-416.[|DOI] [4] Aharoni R, Teitelbaum D, Arnon R, Sela M. Copolymer 1 Acts Against the Immunodominant Epitope 82-100 of Myelin Basic Protein by T Cell Receptor Antagonism in Addition to Major Histocompatibility Complex Blocking 1999 96**(2)** 634-639. [|DOI] [5]Schrempf W, Ziemssen T. Glatiramer Acetate: Mechanisms of action in multiple sclerosis.

[afd] Patent [|DOI]